India In Vitro Diagnostics Market Size, Growth Trends, Demand & Industry Outlook 2025-2033

India In Vitro Diagnostics Market Overview

According to IMARC Group’s report titled "India In Vitro Diagnostics Market Size, Share, Trends and Forecast by Test Type, Product, Usability, Application, End User, and Region, 2025-2033" the report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.

The India in vitro diagnostics market size reached USD 5.3 Billion in 2024 and is projected to reach USD 10.0 Billion by 2033, exhibiting a robust CAGR of 6.84% during the forecast period of 2025-2033. The market growth is driven by increasing incidence of chronic diseases such as diabetes, cardiovascular diseases, and cancer which demand early diagnosis and monitoring via diagnostic tests. Major drivers include rising health awareness and technological advancements in diagnostic modalities.

Industry Key Takeaways

• Current Market Size : USD 5.3 Billion (2024)
• CAGR : 6.84%
• Forecast Period : 2025-2033
• The market is segmented by test type into clinical chemistry, molecular diagnostics, immunodiagnostics, hematology, and others.
• Product segments include reagents and kits, and instruments.
• Usability segments cover disposable IVD devices and reusable IVD devices.
• Applications span infectious diseases, diabetes, cancer/oncology, cardiology, autoimmune disease, nephrology, and others.
• End users consist of hospital laboratories, clinical laboratories, point-of-care testing centers, academic institutes, patients, and others.

Note : We are in the process of updating our reports to cover the 2026–2034 forecast period. For the most recent data, insights, and industry updates, please click on ‘Request Free Sample Report.

Request Free Sample Report : https://www.imarcgroup.com/india-in-vitro-diagnostics-market/requestsample

India In Vitro Diagnostics Market Trends

• Rapid growth in molecular diagnostics driven by advanced technologies like PCR amplification, next-generation sequencing, and CRISPR-based platforms.
• Enhanced diagnostic precision through artificial intelligence and machine learning integration.
• Expansion of point-of-care molecular diagnostic devices, improving accessibility even in remote areas.
• COVID-19 pandemic catalyzed adoption and infrastructure for molecular diagnostics.
• Emergence of cost-effective technologies like digital PCR, isothermal amplification, and microfluidic devices.
• Government initiatives fostering genomic research and precision medicine.
• Heightened importance of infectious disease diagnostics including rapid pathogen detection and antimicrobial resistance testing.
• Increased demand for advanced biomarker testing supporting chronic disease management.
• Development of integrated diagnostic platforms capable of multi-marker testing for chronic and infectious diseases.

India In Vitro Diagnostics Market Growth Factors

• Rising incidence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is fueling demand for diagnostic tests.
• Increasing aging population vulnerable to various health conditions that necessitate precise diagnostics.
• Continuous technological advancements, including molecular diagnostics and personalized medicine integration.
• Growing awareness among patients and healthcare professionals about benefits of early disease detection.
• Expansion of preventive healthcare measures emphasizing point-of-care testing.
• Government schemes such as the Production Linked Incentive (PLI) promoting domestic manufacturing.
• Import substitution policies supporting indigenous IVD device production.
• Expansion opportunities in tier-2 and tier-3 cities due to developing healthcare infrastructure.
• Increasing focus on home healthcare and portable diagnostic solutions.

Buy the Latest 2026 Edition : https://www.imarcgroup.com/checkout?id=21465&method=3462

India In Vitro Diagnostics Market Segmentation

The market is segmented as follows:

Test Type Insights

• Clinical Chemistry
• Molecular Diagnostics
• Immunodiagnostics
• Hematology
• Others

Product Insights

• Reagents and Kits
• Instruments

Usability Insights

• Disposable IVD Devices
• Reusable IVD Devices

Application Insights

• Infectious Disease
• Diabetes
• Cancer/Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Others

End User Insights

• Hospitals Laboratories
• Clinical Laboratories
• Point-of-care Testing Centers
• Academic Institutes
• Patients
• Others

Regional Insights

• North India
• West and Central India
• South India
• East and Northeast India

Competitive landscape:

The report offers an in-depth examination of the competitive landscape, including market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

Recent Developments & News

• In September 2025, India launched the In-Vitro Diagnostics (IVD) validation portal at the National Virus Research & Diagnostic Laboratory (VRDL) Conclave to enhance validation process efficiency and transparency.
• In August 2025, the CDSCO and ICMR issued draft standard evaluation protocols for IVD devices covering 15 types including Dengue, Malaria, and SARS-CoV-2, to streamline licensing.
• In September 2024, Fapon showcased innovative IVD solutions at Medical Fair India 2024 in Mumbai, introducing new biomarkers, reagents, and open-instrument platforms aimed at supporting local manufacturers and improving patient care.

Key Highlights of the Report

• Comprehensive historical and forecast market analysis from 2019 to 2033.
• Segment wise assessment by Test Type, Product, Usability, Application, End User, and Region.
• Insightful analysis of market drivers, challenges, opportunities, and trends.
• Porter’s five forces analysis assessing competitive intensity and market attractiveness.
• Detailed competitive landscape with company profiling and strategic insights.

Get Your Customized Market Report Instantly: https://www.imarcgroup.com/request?type=report&id=21465&flag=C

Note: If you require any specific information not covered within this report’s scope, we will provide it as part of the customization.

About Us

IMARC Group is a global management consulting firm that helps ambitious changemakers create a lasting impact. The company offers comprehensive market assessment, feasibility studies, incorporation support, regulatory assistance, branding and strategy services, and procurement research.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel: (D) +91 120 433 0800

United States: +1-201971-6302